4th Quarter - Report

BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ for CHIMERIX, INC.

Period 4th Quarter 2018 Filed Jan 19, 2019 Signed by Nicole Carelli

Official filing
Firm
BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
Client
CHIMERIX, INC.
Income
$30,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 6378, The Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018, provisions related to authorization for medical countermeasures development and procurement; S. 2852, The Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018, provisions related to authorization for medical countermeasures development and procurement; medical countermeasure development and procurement process, generally.

LobbyistCovered position, as disclosed
NICOLE CARELLI —

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 6378 (115th), S. 2852 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.